The current GOSS market cap is 190.7M. The company's latest EPS is USD -1.0176 and P/E is -0.84.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -53.87M | -56.02M | -54.36M | -47.94M | -46.3M |
Net Income | -56.47M | -59.36M | -55.76M | -49.17M | -42.5M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 799k | 0 |
Operating Income | -148.99M | -186.14M | -233.96M | -215.33M | -218.59M |
Net Income | -146.97M | -180.31M | -243.36M | -234M | -229.38M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 245.84M | 323.54M | 272.45M | 219.91M | 181.75M |
Total Liabilities | 262.31M | 267.19M | 260.37M | 248.36M | 244.55M |
Total Equity | -16.46M | 56.35M | 12.08M | -28.46M | -62.8M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 239.42M | 426.6M | 539.43M | 343.66M | 272.45M |
Total Liabilities | 21.12M | 74.12M | 218.75M | 222.19M | 260.37M |
Total Equity | -120.07M | 352.49M | 320.68M | 121.46M | 12.08M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -102.31M | -139.3M | -187.03M | -52.99M | -91.24M |
Investing | 13.1M | -9.5M | -1.04M | 8.72M | 21.66M |
Financing | 742k | 119.96M | 117.09M | -2.54M | -5.44M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -51.04M | -144.83M | -176.36M | -188.89M | -187.03M |
Investing | -144.71M | -147.14M | 215.34M | -117.43M | -1.04M |
Financing | 300.86M | 321.58M | 312.54M | 3.33M | 117.09M |
Market Cap | 190.7M |
Price to Earnings Ratio | -0.84 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.71 |
Price to Book Ratio | 15.86 |
Dividend Yield | - |
Shares Outstanding | 225.41M |
Average Volume (1 week) | 2.59M |
Average Volume (1 Month) | 2.06M |
52 Week Change | -90.6% |
52 Week High | 9.55 |
52 Week Low | 0.4525 |
Spread (Intraday) | 0.18 (20.84%) |
Company Name | Gossamer Bio Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.gossamerbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.